N. J. DeiulIIs

Insider Reports History

Entity
Individual
Location
1800 Washington Rd., Pittsburgh, PA
Signature
/s/ Sarah Molinero, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by N. J. DeiulIIs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CNX Resources Corp President and CEO, Director Common shares, $0.01 par value per share 2.37M $65M $27.38 Jan 31, 2025 Direct
CNX Resources Corp President and CEO, Director Common shares, $0.01 par value per share 2.35M $50.8M $21.58 Mar 19, 2024 Direct
CNX Resources Corp President and CEO, Director Common shares, $0.01 par value per share 270K $7.4M $27.38 Jan 31, 2025 By DeIuliis 2021 Trust
CNX Resources Corp President and CEO, Director Stock Option (right to buy) 0 Mar 19, 2024 Direct

Insider Reports Filed by N. J. DeiulIIs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNX CNX Resources Corp Jan 31, 2025 5 -$1.78M 4 Feb 4, 2025 President and CEO, Director
CNX CNX Resources Corp Jan 3, 2025 2 -$1.42M 4 Jan 7, 2025 President and CEO, Director
CNX CNX Resources Corp Mar 19, 2024 3 -$5.13M 4 Mar 21, 2024 President and CEO, Director
CNX CNX Resources Corp Jan 31, 2024 7 -$3.2M 4 Feb 2, 2024 President and CEO, Director
CNX CNX Resources Corp Jan 3, 2024 4 -$1.27M 4 Jan 5, 2024 President and CEO, Director
CNX CNX Resources Corp Jan 31, 2023 6 $317K 4 Feb 2, 2023 President and CEO, Director
CNX CNX Resources Corp Jan 4, 2023 1 -$482K 4 Jan 6, 2023 President and CEO, Director
CNX CNX Resources Corp Jan 2, 2023 3 $546K 4 Jan 4, 2023 President and CEO, Director
CNX CNX Resources Corp Apr 20, 2022 1 $0 4 Apr 21, 2022 President and CEO, Director
CNX CNX Resources Corp Mar 28, 2022 1 $0 4 Mar 30, 2022 President and CEO, Director
CNX CNX Resources Corp Jan 31, 2022 3 -$615K 4 Feb 2, 2022 President and CEO, Director
CNX CNX Resources Corp Jan 3, 2022 4 -$977K 4 Jan 5, 2022 President and CEO, Director